ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Survival Benefit from Kidney Transplantation Using Kidneys from Deceased Donors Over 75 Years.

M. Pérez-Sáez,1 E. Arcos,2 J. Comas,2 M. Crespo,1 J. Lloveras,1 J. Tort,2 J. Pascual,1 Catalan Renal Registry Committee.2

1Nephrology, Hospital del Mar, Barcelona, Spain
2Catalan Renal Registry, Organització
Catalana de Trasplantaments, Barcelona, Spain.

Meeting: 2016 American Transplant Congress

Abstract number: B184

Keywords: Donors, Kidney transplantation, marginal, Outcome

Session Information

Date: Sunday, June 12, 2016

Session Name: Poster Session B: Kidney Transplantation: KDPI, HCV/Matching, Donor Age

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • Utilization of Kidneys from Deceased Donors With Acute Kidney Injury
  • Poor Renal Function and Increased Mortality in Elderly Recipients of Deceased Donor Kidneys from Elderly Donors

Large registries have shown that end-stage renal disease patients have longer survival after kidney transplantation (KT) than remaining on dialysis. However, the outcome for kidneys from donors ≥75 years and the survival of recipients of these organs compared to their dialysis counterparts with the same probability to obtain an organ, is unknown. We assessed outcomes of 5,974 deceased-donor recipients, 415 of whom received kidneys from donors ≥75 years. We aimed to pair each eligible case with one control that initiated dialysis before 2013 and that at some point were included in the waiting list for KT but were not transplanted during the whole study period. Controls had similar characteristics at the time of starting dialysis: age, sex, primary renal disease, cardiovascular comorbidities, history of malignant tumor or chronic liver disease. We found 371 pairs. Patients who received a kidney from an ≥75 year-old donor had a mean age of 68,7±5,8 years. Most of those kidneys (92.8%) were allocated to recipients ≥60 years-old. The whole cohort of 742 patients (371 KT and 371 dialysis controls) was followed-up for a maximum of 16 years, with a median of 2.9 years. During the whole observation period, there were 127 deaths (34.2%) among the KT group and 205 (55.2%) among the controls. Patient survival was higher for transplanted patients than those on dialysis remaining waitlisted at 1, 3, 5, and 10 years (90.7%, 83.6%, 72.5% and 49.3% vs. 87.9%, 65.6%, 48.5%, and 16.1%, respectively: adjusted proportional risk of death 2.18 [95%CI 1.72-2.76, p<0.001])[figure1]. Stratifying by age, hazard ratio for death in dialysis partners was 5.48 (95%CI 2.92-10.28) in patients <65y, 1.93 (1.24–3.00) in 65-69y, 1.61 (1.17–2.21) in those 70-74y and 1.39 (95%CI 0.40–1.16) in ≥75 year-olds. KT from donors ≥75 years-old is associated with an acceptable 66.5% 10-year death-censored graft survival. Overall, patients remaining on dialysis with a comparable chance of obtaining an organ, have a two-fold higher risk of death than those who receive an organ from a ≥75 donor. Moreover, this benefit is higher in recipients younger than 65, losing significance in elderly recipients ≥75.

CITATION INFORMATION: Pérez-Sáez M, Arcos E, Comas J, Crespo M, Lloveras J, Tort J, Pascual J, Catalan Renal Registry Committee Survival Benefit from Kidney Transplantation Using Kidneys from Deceased Donors Over 75 Years. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Pérez-Sáez M, Arcos E, Comas J, Crespo M, Lloveras J, Tort J, Pascual J, Committee CatalanRenalRegistry. Survival Benefit from Kidney Transplantation Using Kidneys from Deceased Donors Over 75 Years. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/survival-benefit-from-kidney-transplantation-using-kidneys-from-deceased-donors-over-75-years/. Accessed March 4, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.